111 related articles for article (PubMed ID: 21837771)
1. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Lüthi F; Leibundgut K; Niggli FK; Nadal D; Aebi C; Bodmer N; Ammann RA
Pediatr Blood Cancer; 2012 Jul; 59(1):90-5. PubMed ID: 21837771
[TBL] [Abstract][Full Text] [Related]
2. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
3. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
4. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
[TBL] [Abstract][Full Text] [Related]
5. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
[TBL] [Abstract][Full Text] [Related]
7. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
8. Risk of mortality in patients with cancer who experience febrile neutropenia.
Lyman GH; Michels SL; Reynolds MW; Barron R; Tomic KS; Yu J
Cancer; 2010 Dec; 116(23):5555-63. PubMed ID: 20715160
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
[TBL] [Abstract][Full Text] [Related]
11. Presumptive treatment for malaria is not justified in children receiving cancer chemotherapy.
Bansal D; Gautam P; Dubey ML; Marwaha RK
Pediatr Blood Cancer; 2010 Dec; 55(6):1108-10. PubMed ID: 20979171
[TBL] [Abstract][Full Text] [Related]
12. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
13. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
15. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.
Binz P; Bodmer N; Leibundgut K; Teuffel O; Niggli FK; Ammann RA
Pediatr Blood Cancer; 2013 May; 60(5):799-805. PubMed ID: 23193083
[TBL] [Abstract][Full Text] [Related]
16. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
[TBL] [Abstract][Full Text] [Related]
17. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
Yilmaz S; Oren H; Demircioğlu F; Irken G
Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
[TBL] [Abstract][Full Text] [Related]
18. Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study.
Bagnasco F; Haupt R; Fontana V; Valsecchi MG; Rebora P; Caviglia I; Caruso S; Castagnola E
J Chemother; 2012 Jun; 24(3):155-60. PubMed ID: 22759760
[TBL] [Abstract][Full Text] [Related]
19. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
Paganini HR; Rodríguez Brieshcke T; Zubizarreta P; Latella A; Firpo V; Fernandez C; Armada A; Casimir L; Debbag R
Medicina (B Aires); 2001; 61(1):63-6. PubMed ID: 11265626
[TBL] [Abstract][Full Text] [Related]
20. Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.
Ammann RA; Aebi C; Hirt A; Ridolfi Lüthy A
Support Care Cancer; 2004 Dec; 12(12):826-32. PubMed ID: 15243791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]